CA3187416A1 - Procede et systemes de communication et d'interaction a l'aide de donnees de mouvements humains en 3d - Google Patents
Procede et systemes de communication et d'interaction a l'aide de donnees de mouvements humains en 3dInfo
- Publication number
- CA3187416A1 CA3187416A1 CA3187416A CA3187416A CA3187416A1 CA 3187416 A1 CA3187416 A1 CA 3187416A1 CA 3187416 A CA3187416 A CA 3187416A CA 3187416 A CA3187416 A CA 3187416A CA 3187416 A1 CA3187416 A1 CA 3187416A1
- Authority
- CA
- Canada
- Prior art keywords
- movement
- movement data
- human
- input
- facial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000033001 locomotion Effects 0.000 title claims abstract description 559
- 241000282414 Homo sapiens Species 0.000 title claims abstract description 145
- 238000000034 method Methods 0.000 title claims abstract description 134
- 238000004891 communication Methods 0.000 title claims abstract description 67
- 230000003993 interaction Effects 0.000 title description 10
- 230000001337 psychedelic effect Effects 0.000 claims abstract description 43
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 30
- 230000002452 interceptive effect Effects 0.000 claims abstract description 16
- 230000001815 facial effect Effects 0.000 claims description 45
- 238000009877 rendering Methods 0.000 claims description 39
- 230000000007 visual effect Effects 0.000 claims description 18
- 230000010354 integration Effects 0.000 claims description 8
- 230000005021 gait Effects 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 7
- 238000007405 data analysis Methods 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 238000006213 oxygenation reaction Methods 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 230000003190 augmentative effect Effects 0.000 abstract description 4
- 238000001671 psychotherapy Methods 0.000 description 37
- 210000001503 joint Anatomy 0.000 description 31
- 230000008569 process Effects 0.000 description 17
- 238000012545 processing Methods 0.000 description 17
- 230000008451 emotion Effects 0.000 description 16
- 238000007664 blowing Methods 0.000 description 15
- 238000010586 diagram Methods 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 238000004422 calculation algorithm Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 238000013461 design Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 210000003414 extremity Anatomy 0.000 description 7
- 210000002414 leg Anatomy 0.000 description 7
- 210000002683 foot Anatomy 0.000 description 6
- 238000010801 machine learning Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000004630 mental health Effects 0.000 description 5
- 230000003997 social interaction Effects 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 238000012800 visualization Methods 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000008921 facial expression Effects 0.000 description 4
- 230000036544 posture Effects 0.000 description 4
- 239000003196 psychodysleptic agent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001755 vocal effect Effects 0.000 description 4
- 238000012935 Averaging Methods 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 238000004497 NIR spectroscopy Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004931 aggregating effect Effects 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000004247 hand Anatomy 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 2
- 101150066718 FMOD gene Proteins 0.000 description 2
- -1 LSD) Chemical class 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- QVDSEJDULKLHCG-UHFFFAOYSA-N Psilocybine Natural products C1=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CNC2=C1 QVDSEJDULKLHCG-UHFFFAOYSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008933 bodily movement Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000019771 cognition Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000000537 electroencephalography Methods 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 230000004424 eye movement Effects 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 239000000380 hallucinogen Substances 0.000 description 2
- 210000002478 hand joint Anatomy 0.000 description 2
- 230000009191 jumping Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- RHCSKNNOAZULRK-UHFFFAOYSA-N mescaline Chemical compound COC1=CC(CCN)=CC(OC)=C1OC RHCSKNNOAZULRK-UHFFFAOYSA-N 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 208000028173 post-traumatic stress disease Diseases 0.000 description 2
- QKTAAWLCLHMUTJ-UHFFFAOYSA-N psilocybin Chemical compound C1C=CC(OP(O)(O)=O)=C2C(CCN(C)C)=CN=C21 QKTAAWLCLHMUTJ-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000007794 visualization technique Methods 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 102000049773 5-HT2A Serotonin Receptor Human genes 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 229910000497 Amalgam Inorganic materials 0.000 description 1
- 238000000767 Anderson–Darling test Methods 0.000 description 1
- 208000023514 Barrett esophagus Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 241000435122 Echinopsis terscheckii Species 0.000 description 1
- OBSYBRPAKCASQB-UHFFFAOYSA-N Episalvinorin A Natural products COC(=O)C1CC(OC(C)=O)C(=O)C(C2(C3)C)C1(C)CCC2C(=O)OC3C=1C=COC=1 OBSYBRPAKCASQB-UHFFFAOYSA-N 0.000 description 1
- 238000001162 G-test Methods 0.000 description 1
- 101150104779 HTR2A gene Proteins 0.000 description 1
- 238000001207 Hosmer–Lemeshow test Methods 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
- 238000001283 Kuiper's test Methods 0.000 description 1
- 241000883511 Lophophora williamsii Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241000258241 Mantis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- DMULVCHRPCFFGV-UHFFFAOYSA-N N,N-dimethyltryptamine Chemical compound C1=CC=C2C(CCN(C)C)=CNC2=C1 DMULVCHRPCFFGV-UHFFFAOYSA-N 0.000 description 1
- WJJGAKCAAJOICV-UHFFFAOYSA-N N-dimethyltyrosine Natural products CN(C)C(C(O)=O)CC1=CC=C(O)C=C1 WJJGAKCAAJOICV-UHFFFAOYSA-N 0.000 description 1
- ZVOOGERIHVAODX-UHFFFAOYSA-N O-demycinosyltylosin Natural products O=CCC1CC(C)C(=O)C=CC(C)=CC(CO)C(CC)OC(=O)CC(O)C(C)C1OC1C(O)C(N(C)C)C(OC2OC(C)C(O)C(C)(O)C2)C(C)O1 ZVOOGERIHVAODX-UHFFFAOYSA-N 0.000 description 1
- 238000001358 Pearson's chi-squared test Methods 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- SPCIYGNTAMCTRO-UHFFFAOYSA-N Psilocine Natural products C1=CC(O)=C2C(CCN(C)C)=CNC2=C1 SPCIYGNTAMCTRO-UHFFFAOYSA-N 0.000 description 1
- 238000011869 Shapiro-Wilk test Methods 0.000 description 1
- 208000028552 Treatment-Resistant Depressive disease Diseases 0.000 description 1
- VOXIUXZAOFEFBL-UHFFFAOYSA-N Voacangin Natural products CCC1CC2CN3CC1C(C2)(OC(=O)C)c4[nH]c5ccc(OC)cc5c4C3 VOXIUXZAOFEFBL-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940060585 alora Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000022266 body dysmorphic disease Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012517 data analytics Methods 0.000 description 1
- 238000013144 data compression Methods 0.000 description 1
- 238000007418 data mining Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000002566 electrocorticography Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- HSIBGVUMFOSJPD-CFDPKNGZSA-N ibogaine Chemical compound N1([C@@H]2[C@H]3C[C@H](C1)C[C@@H]2CC)CCC1=C3NC2=CC=C(OC)C=C12 HSIBGVUMFOSJPD-CFDPKNGZSA-N 0.000 description 1
- OLOCMRXSJQJJPL-UHFFFAOYSA-N ibogaine Natural products CCC1CC2CC3C1N(C2)C=Cc4c3[nH]c5ccc(OC)cc45 OLOCMRXSJQJJPL-UHFFFAOYSA-N 0.000 description 1
- AREITJMUSRHSBK-UHFFFAOYSA-N ibogamine Natural products CCC1CC2C3CC1CN2CCc4c3[nH]c5ccccc45 AREITJMUSRHSBK-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000008511 lysergamides Chemical class 0.000 description 1
- 238000002582 magnetoencephalography Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- ZBWSBXGHYDWMAK-UHFFFAOYSA-N psilocin Chemical compound C1=CC=C(O)[C]2C(CCN(C)C)=CN=C21 ZBWSBXGHYDWMAK-UHFFFAOYSA-N 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- OBSYBRPAKCASQB-AGQYDFLVSA-N salvinorin A Chemical compound C=1([C@H]2OC(=O)[C@@H]3CC[C@]4(C)[C@@H]([C@]3(C2)C)C(=O)[C@@H](OC(C)=O)C[C@H]4C(=O)OC)C=COC=1 OBSYBRPAKCASQB-AGQYDFLVSA-N 0.000 description 1
- IQXUYSXCJCVVPA-UHFFFAOYSA-N salvinorin A Natural products CC(=O)OC1CC(OC(=O)C)C2(C)CCC34CC(CC3(C)C2C1=O)(OC4=O)c5occc5 IQXUYSXCJCVVPA-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 230000009295 sperm incapacitation Effects 0.000 description 1
- 238000013403 standard screening design Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- WOZVHXUHUFLZGK-UHFFFAOYSA-N terephthalic acid dimethyl ester Natural products COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T13/00—Animation
- G06T13/20—3D [Three Dimensional] animation
- G06T13/40—3D [Three Dimensional] animation of characters, e.g. humans, animals or virtual beings
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/011—Arrangements for interaction with the human body, e.g. for user immersion in virtual reality
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/01—Input arrangements or combined input and output arrangements for interaction between user and computer
- G06F3/017—Gesture based interaction, e.g. based on a set of recognized hand gestures
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V20/00—Scenes; Scene-specific elements
- G06V20/20—Scenes; Scene-specific elements in augmented reality scenes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
- G06V40/20—Movements or behaviour, e.g. gesture recognition
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Engineering & Computer Science (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Human Computer Interaction (AREA)
- Multimedia (AREA)
- Social Psychology (AREA)
- Psychiatry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Processing Or Creating Images (AREA)
- User Interface Of Digital Computer (AREA)
- Information Transfer Between Computers (AREA)
Abstract
L'invention concerne des procédés et systèmes d'utilisation de données de mouvements humains en trois dimensions en tant que moyen interactif et synesthésique de communication autorisant le partage de langage corporel entre et parmi des individus et des groupes, permettant de bénéficier de moyens inédits d'expression et de partage et formant le fondement d'un nouveau type de support doté de nombreuses applications, par exemple dans le cadre d'une application de thérapie assistée par psychédélique ou pour l'améliorer, en particulier lorsque cette thérapie incorpore une réalité augmentée ou virtuelle.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057873P | 2020-07-28 | 2020-07-28 | |
| US63/057,873 | 2020-07-28 | ||
| PCT/US2021/043580 WO2022026630A1 (fr) | 2020-07-28 | 2021-07-28 | Procédé et systèmes de communication et d'interaction à l'aide de données de mouvements humains en 3d |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3187416A1 true CA3187416A1 (fr) | 2022-02-03 |
Family
ID=80036078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3187416A Pending CA3187416A1 (fr) | 2020-07-28 | 2021-07-28 | Procede et systemes de communication et d'interaction a l'aide de donnees de mouvements humains en 3d |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4189594A1 (fr) |
| CA (1) | CA3187416A1 (fr) |
| WO (1) | WO2022026630A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117132687B (zh) * | 2023-08-14 | 2024-06-11 | 北京元跃科技有限公司 | 一种动画生成方法、装置及电子设备 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8407756B2 (en) * | 2009-09-22 | 2013-03-26 | At&T Intellectual Property I, L.P. | Systems and methods for remote web query and image selection exchange to video screen |
| US9325936B2 (en) * | 2013-08-09 | 2016-04-26 | Samsung Electronics Co., Ltd. | Hybrid visual communication |
| US9974478B1 (en) * | 2014-12-19 | 2018-05-22 | Great Lakes Neurotechnologies Inc. | Discreet movement measurement and cueing system for improvement of safety and efficacy of movement |
| US10210648B2 (en) * | 2017-05-16 | 2019-02-19 | Apple Inc. | Emojicon puppeting |
| US10657695B2 (en) * | 2017-10-30 | 2020-05-19 | Snap Inc. | Animated chat presence |
| CN111443619B (zh) * | 2020-04-17 | 2021-06-08 | 南京工程学院 | 一种虚实融合的人机协作仿真方法和系统 |
-
2021
- 2021-07-28 WO PCT/US2021/043580 patent/WO2022026630A1/fr active Search and Examination
- 2021-07-28 CA CA3187416A patent/CA3187416A1/fr active Pending
- 2021-07-28 EP EP21850506.3A patent/EP4189594A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022026630A1 (fr) | 2022-02-03 |
| EP4189594A1 (fr) | 2023-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11450073B1 (en) | Multi-user virtual and augmented reality tracking systems | |
| Harley et al. | Tangible vr: Diegetic tangible objects for virtual reality narratives | |
| Hsueh et al. | Understanding kinaesthetic creativity in dance | |
| Tsoupikova et al. | Virtual immersion for post-stroke hand rehabilitation therapy | |
| Gillies | Understanding the role of interactive machine learning in movement interaction design | |
| US20160096072A1 (en) | Method and system for detecting, tracking, and visualizing joint therapy data | |
| Vourvopoulos et al. | Brain-controlled serious games for cultural heritage | |
| US20180373324A1 (en) | Systems and processes for providing virtual sexual experiences | |
| US10835802B1 (en) | Physiological response management using computer-implemented activities | |
| Liang et al. | Exploitation of novel multiplayer gesture-based interaction and virtual puppetry for digital storytelling to develop children's narrative skills | |
| Oğuz’Oz’Buruk et al. | Towards the next generation of gaming wearables | |
| US20240065622A1 (en) | Methods and systems for the use of 3d human movement data | |
| Chen et al. | Virtual, Augmented and Mixed Reality: Interaction, Navigation, Visualization, Embodiment, and Simulation: 10th International Conference, VAMR 2018, Held as Part of HCI International 2018, Las Vegas, NV, USA, July 15-20, 2018, Proceedings, Part I | |
| CA3187416A1 (fr) | Procede et systemes de communication et d'interaction a l'aide de donnees de mouvements humains en 3d | |
| Dix et al. | TouchIT: Understanding Design in a Physical-Digital World | |
| Carvajal et al. | Robotic applications in virtual environments for children with autism | |
| Chen et al. | Virtual, Augmented and Mixed Reality: Applications in Health, Cultural Heritage, and Industry: 10th International Conference, VAMR 2018, Held as Part of HCI International 2018, Las Vegas, NV, USA, July 15-20, 2018, Proceedings, Part II | |
| Chang | Catching the ghost: the digital gaze of motion capture | |
| Takacs | Cognitive, Mental and Physical Rehabilitation Using a Configurable Virtual Reality System. | |
| Dawson | A discussion of immersion in human computer interaction: the immersion model of user experience | |
| Lenders | Physical Perception of a VR Handshake | |
| Grillon | Simulating interactions with virtual characters for the treatment of social phobia | |
| Primett | Non-Verbal Communication with Physiological Sensors the Aesthetic Domain of Wearables and Neural Networks | |
| Leniston-Kahsai | Mirror VR: The design of a fully immersive virtual reality game for upper limb rehabilitation post-stroke using mirror therapy | |
| Vogiatzaki et al. | Rehabilitation after stroke using immersive user interfaces in 3D virtual and augmented gaming environments |